GSTO1 and cancer: Studies have found that double gene knockout of GSTO1 and TNFαIP3/A20 using the CRISPR/Cas9 system is more sensitive to chemotherapy drugs than single gene knockout, and the apoptosis of cancer cells increases, which reveals that GSTO1 can enhance the drug resistance of cancer cells (49).